Myeong-Ki Hong, MD. Ph D, on behalf of RESET investigators Professor, Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College.
Four Drug Eluting Stent Trials Keith D Dawkins MD FRCP FACC Southampton University Hospital Keith D Dawkins MD FRCP FACC Southampton University Hospital.
Klinikum Rosenheim Department of Diagnostic and Interventional Radiology LINC 2014 DEFINITIVE AR Severe Ca++ Arm 30-Day Results Gunnar Tepe, MD On behalf.
Ranolazine in Patients with Incomplete Revascularization After Percutaneous Coronary Intervention Giora Weisz, MD Philippe Généreux, Andres Iñiguez, Aleksander.
Two Year Safety And Clinical Performance Of The Drug Eluting Orsiro Stent In The Treatment Of Subjects With Single De Novo Coronary Artery Lesions (BIOFLOW-II)
Tony Gershlick University Hospitals of Leicester UK
Clinical Writing for Interventional Cardiologists
DEFINITIVE AR - Acute Outcomes -
Myeong-Ki Hong , MD. Ph D, on behalf of RESET investigators Professor, Division of Cardiology,
